Evolution and transmission of drug-resistant tuberculosis in a Russian population
- PMID: 24464101
- PMCID: PMC3939361
- DOI: 10.1038/ng.2878
Evolution and transmission of drug-resistant tuberculosis in a Russian population
Abstract
The molecular mechanisms determining the transmissibility and prevalence of drug-resistant tuberculosis in a population were investigated through whole-genome sequencing of 1,000 prospectively obtained patient isolates from Russia. Two-thirds belonged to the Beijing lineage, which was dominated by two homogeneous clades. Multidrug-resistant (MDR) genotypes were found in 48% of isolates overall and in 87% of the major clades. The most common rpoB mutation was associated with fitness-compensatory mutations in rpoA or rpoC, and a new intragenic compensatory substitution was identified. The proportion of MDR cases with extensively drug-resistant (XDR) tuberculosis was 16% overall, with 65% of MDR isolates harboring eis mutations, selected by kanamycin therapy, which may drive the expansion of strains with enhanced virulence. The combination of drug resistance and compensatory mutations displayed by the major clades confers clinical resistance without compromising fitness and transmissibility, showing that, in addition to weaknesses in the tuberculosis control program, biological factors drive the persistence and spread of MDR and XDR tuberculosis in Russia and beyond.
Figures






Similar articles
-
Microevolution of extensively drug-resistant tuberculosis in Russia.Genome Res. 2012 Apr;22(4):735-45. doi: 10.1101/gr.128678.111. Epub 2012 Jan 31. Genome Res. 2012. PMID: 22294518 Free PMC article.
-
Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan.Infect Genet Evol. 2019 Aug;72:141-146. doi: 10.1016/j.meegid.2018.12.031. Epub 2018 Dec 26. Infect Genet Evol. 2019. PMID: 30593924
-
Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.BMC Infect Dis. 2018 Feb 27;18(1):98. doi: 10.1186/s12879-018-3009-9. BMC Infect Dis. 2018. PMID: 29486710 Free PMC article.
-
Mechanisms of drug resistance in Mycobacterium tuberculosis.Int J Tuberc Lung Dis. 2009 Nov;13(11):1320-30. Int J Tuberc Lung Dis. 2009. PMID: 19861002 Review.
-
Highly transmitted M. tuberculosis strains are more likely to evolve MDR/XDR and cause outbreaks, but what makes them highly transmitted?Tuberculosis (Edinb). 2021 Jul;129:102092. doi: 10.1016/j.tube.2021.102092. Epub 2021 Jun 2. Tuberculosis (Edinb). 2021. PMID: 34102584 Review.
Cited by
-
Fitness Costs of Drug Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis: A Household-Based Case-Control Study.J Infect Dis. 2016 Jan 1;213(1):149-55. doi: 10.1093/infdis/jiv347. Epub 2015 Jun 19. J Infect Dis. 2016. PMID: 26092854 Free PMC article.
-
Analysis of IS6110 insertion sites provide a glimpse into genome evolution of Mycobacterium tuberculosis.Sci Rep. 2015 Jul 28;5:12567. doi: 10.1038/srep12567. Sci Rep. 2015. PMID: 26215170 Free PMC article.
-
Polyketide synthases mutation in tuberculosis transmission revealed by whole genomic sequence, China, 2011-2019.Front Genet. 2024 Jan 8;14:1217255. doi: 10.3389/fgene.2023.1217255. eCollection 2023. Front Genet. 2024. PMID: 38259610 Free PMC article.
-
Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape.Antimicrob Agents Chemother. 2016 Jun 20;60(7):3994-4004. doi: 10.1128/AAC.00222-16. Print 2016 Jul. Antimicrob Agents Chemother. 2016. PMID: 27090176 Free PMC article.
-
Impacts of social support on the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis.BMJ Open. 2020 Oct 8;10(10):e036985. doi: 10.1136/bmjopen-2020-036985. BMJ Open. 2020. PMID: 33033087 Free PMC article.
References
-
- World Health Organisation Global tuberculosis report. 2012
-
- Gandhi NR, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375:1830–1843. - PubMed
-
- London Health Protection Agency Tuberculosis in the UK: annual report on tuberculosis surveillance in the UK. 2012
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources